The field of human genetics and genomics is expanding faster than any other area of science, and our findings are leading to whole new understandings of a myriad of diseases and normal human states.

At the Feinstein Institute’s Robert S. Boas Center for Genomics and Human Genetics, our scientists are combing the genome to find risk genes for a number of common human conditions – from autoimmune disorders like lupus and rheumatoid arthritis, to Alzheimer’s disease and schizophrenia. We are also pursuing the identification of genes for absolute pitch and a fascinating sensory condition called synesthesia, as well as other human traits related to memory and cognition.

Our scientists have played a major role in identifying the risk genes involved in systemic lupus erythematosus, and we are leading or participating in international efforts to define the genetics of autoimmune diseases such as rheumatoid arthritis, Myasthenia Gravis, Alopecia Areata, Polymyositis, and IgA deficiency.

In addition, Feinstein Institute researchers are studying genetic traits in order to determine new treatments for people who suffer from breast and ovarian cancer. These new approaches aim at directing proper treatments and early detection for these diseases.

Principal investigators for genetic research include Peter Davies; Betty Diamond; Peter K. Gregersen; Annette T. Lee; Todd Lencz; Jeffrey M. Lipton and Anil Malhotra.